NextGen Healthcare, Inc.

NasdaqGS:NXGN Stock Report

Market Cap: US$1.6b

NextGen Healthcare Future Growth

Future criteria checks 3/6

NextGen Healthcare is forecast to grow earnings and revenue by 41.8% and 6.7% per annum respectively while EPS is expected to grow by 42.6% per annum.

Key information

41.8%

Earnings growth rate

42.6%

EPS growth rate

Healthcare Services earnings growth31.0%
Revenue growth rate6.7%
Future return on equityn/a
Analyst coverage

Good

Last updated25 Oct 2023

Recent future growth updates

NextGen Healthcare, Inc. Just Recorded A 16% EPS Beat: Here's What Analysts Are Forecasting Next

Jul 27
NextGen Healthcare, Inc. Just Recorded A 16% EPS Beat: Here's What Analysts Are Forecasting Next

Recent updates

Is There An Opportunity With NextGen Healthcare, Inc.'s (NASDAQ:NXGN) 49% Undervaluation?

Aug 24
Is There An Opportunity With NextGen Healthcare, Inc.'s (NASDAQ:NXGN) 49% Undervaluation?

NextGen Healthcare, Inc. Just Recorded A 16% EPS Beat: Here's What Analysts Are Forecasting Next

Jul 27
NextGen Healthcare, Inc. Just Recorded A 16% EPS Beat: Here's What Analysts Are Forecasting Next

Investors Will Want NextGen Healthcare's (NASDAQ:NXGN) Growth In ROCE To Persist

Jul 13
Investors Will Want NextGen Healthcare's (NASDAQ:NXGN) Growth In ROCE To Persist

We Think NextGen Healthcare (NASDAQ:NXGN) Can Manage Its Debt With Ease

Jun 08
We Think NextGen Healthcare (NASDAQ:NXGN) Can Manage Its Debt With Ease

Calculating The Fair Value Of NextGen Healthcare, Inc. (NASDAQ:NXGN)

May 19
Calculating The Fair Value Of NextGen Healthcare, Inc. (NASDAQ:NXGN)

What Does NextGen Healthcare, Inc.'s (NASDAQ:NXGN) Share Price Indicate?

Mar 14
What Does NextGen Healthcare, Inc.'s (NASDAQ:NXGN) Share Price Indicate?

We Think NextGen Healthcare (NASDAQ:NXGN) Can Manage Its Debt With Ease

Feb 27
We Think NextGen Healthcare (NASDAQ:NXGN) Can Manage Its Debt With Ease

Is NextGen Healthcare, Inc. (NASDAQ:NXGN) Expensive For A Reason? A Look At Its Intrinsic Value

Dec 08
Is NextGen Healthcare, Inc. (NASDAQ:NXGN) Expensive For A Reason? A Look At Its Intrinsic Value

These Return Metrics Don't Make NextGen Healthcare (NASDAQ:NXGN) Look Too Strong

Oct 27
These Return Metrics Don't Make NextGen Healthcare (NASDAQ:NXGN) Look Too Strong

At US$17.85, Is It Time To Put NextGen Healthcare, Inc. (NASDAQ:NXGN) On Your Watch List?

Sep 30
At US$17.85, Is It Time To Put NextGen Healthcare, Inc. (NASDAQ:NXGN) On Your Watch List?

NextGen Enterprise solution to be used by NY-based health center

Sep 28

NextGen Healthcare, Inc.'s (NASDAQ:NXGN) Intrinsic Value Is Potentially 75% Above Its Share Price

Sep 07
NextGen Healthcare, Inc.'s (NASDAQ:NXGN) Intrinsic Value Is Potentially 75% Above Its Share Price

NextGen Healthcare (NASDAQ:NXGN) Is Finding It Tricky To Allocate Its Capital

Jul 29
NextGen Healthcare (NASDAQ:NXGN) Is Finding It Tricky To Allocate Its Capital

NextGen Healthcare Non-GAAP EPS of $0.16 in-line, revenue of $153.3M in-line, 2023 revenue outlook below estimates

Jul 26

Is It Too Late To Consider Buying NextGen Healthcare, Inc. (NASDAQ:NXGN)?

May 17
Is It Too Late To Consider Buying NextGen Healthcare, Inc. (NASDAQ:NXGN)?

NextGen At A Crossroads

Oct 13

Is There An Opportunity With NextGen Healthcare, Inc.'s (NASDAQ:NXGN) 44% Undervaluation?

Jun 29
Is There An Opportunity With NextGen Healthcare, Inc.'s (NASDAQ:NXGN) 44% Undervaluation?

Earnings and Revenue Growth Forecasts

NasdaqGS:NXGN - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/202682485851313
3/31/202577062731018
3/31/20247193912638
9/30/2023695-6-43-8N/A
6/30/20236782440N/A
3/31/2023653-3644N/A
12/31/2022626231653N/A
9/30/2022614203267N/A
6/30/202260401849N/A
3/31/202259622554N/A
12/31/202158913159N/A
9/30/2021581-44271N/A
6/30/2021572135381N/A
3/31/2021557107099N/A
12/31/202054967297N/A
9/30/2020545106893N/A
6/30/202053956286N/A
3/31/202054075986N/A
12/31/2019539165382N/A
9/30/2019532164976N/A
6/30/2019528233764N/A
3/31/2019529242550N/A
12/31/2018530102652N/A
9/30/201853162451N/A
6/30/201853313563N/A
3/31/201853124574N/A
12/31/2017528185784N/A
9/30/2017524276792N/A
6/30/201751823N/A111N/A
3/31/201751018N/A110N/A
12/31/2016505-2N/A95N/A
9/30/2016494-6N/A83N/A
6/30/2016493-1N/A50N/A
3/31/20164926N/A41N/A
12/31/201549333N/A51N/A
9/30/201549932N/A54N/A
6/30/201549429N/A68N/A
3/31/201549027N/A83N/A
12/31/201447722N/A91N/A
9/30/20144623N/A103N/A
6/30/20144538N/A91N/A
3/31/201444516N/A104N/A
12/31/20134416N/A95N/A
9/30/201344635N/A82N/A
6/30/201345140N/A80N/A
3/31/201346043N/A68N/A
12/31/201245862N/A61N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: NXGN is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.2%).

Earnings vs Market: NXGN is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: NXGN is expected to become profitable in the next 3 years.

Revenue vs Market: NXGN's revenue (6.7% per year) is forecast to grow slower than the US market (8.1% per year).

High Growth Revenue: NXGN's revenue (6.7% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if NXGN's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y